Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Radical cystectomy and urinary diversion in women: techniques, outcomes, and challenges-a narrative review

M. von Deimling, E. Laukhtina, B. Pradere, M. Pallauf, J. Klemm, M. Fisch, SF. Shariat, M. Rink

. 2022 ; 11 (11) : 1598-1610. [pub] -

Status neindexováno Jazyk angličtina Země Čína

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22031377

BACKGROUND AND OBJECTIVE: Standard radical cystectomy (RC) in women includes the removal of the bladder, urethra, uterus with the adnexa, and the anterior vaginal wall, thereby severely affecting the urinary, sexual, and reproductive system. To limit these detrimental effects, organ-sparing, including nerve-sparing approaches, have been developed. Health-related quality of life (HRQOL) and functional outcomes are, indeed, becoming increasingly central to the shared decision-making with the patient. The objectives of this narrative review are: (I) to review the current status of RC in women, including the use of different urinary diversions (UDs); (II) to discuss organ-sparing approaches and their impact on oncological and functional outcomes in women; (III) to discuss the impact of RC on HRQOL and sexual function in women. METHODS: We performed a non-systematic literature review of the available publications in the PubMed database. KEY CONTENT AND FINDINGS: Over the past years, gender differences in oncological and functional outcomes after RC have received increased attention. According to the currently available literature, organ-sparing approaches can be safely performed in well-selected women without negatively impacting oncological outcomes. The orthotopic neobladder is feasible and oncologically safe in well-selected and informed women. The choice of the UD should be based on comprehensive counseling and the patient's comorbidities and preferences. There still is a lack of data on sexual recovery after the different surgical approaches aimed to mitigate sexual dysfunction in women undergoing RC. CONCLUSIONS: Pre-and post-operative counseling and support of females undergoing RC regarding their expectations and experiences in terms of quality of life and functional and sexual outcomes are currently insufficient. Well-designed studies in this field are necessary to further improve outcomes of women treated with RC with an overarching aim to close the gender gap in managing women with bladder cancer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22031377
003      
CZ-PrNML
005      
20230127131140.0
007      
ta
008      
230119s2022 cc f 000 0|eng||
009      
AR
024    7_
$a 10.21037/tau-22-463 $2 doi
035    __
$a (PubMed)36507477
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a cc
100    1_
$a von Deimling, Markus $u Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
245    10
$a Radical cystectomy and urinary diversion in women: techniques, outcomes, and challenges-a narrative review / $c M. von Deimling, E. Laukhtina, B. Pradere, M. Pallauf, J. Klemm, M. Fisch, SF. Shariat, M. Rink
520    9_
$a BACKGROUND AND OBJECTIVE: Standard radical cystectomy (RC) in women includes the removal of the bladder, urethra, uterus with the adnexa, and the anterior vaginal wall, thereby severely affecting the urinary, sexual, and reproductive system. To limit these detrimental effects, organ-sparing, including nerve-sparing approaches, have been developed. Health-related quality of life (HRQOL) and functional outcomes are, indeed, becoming increasingly central to the shared decision-making with the patient. The objectives of this narrative review are: (I) to review the current status of RC in women, including the use of different urinary diversions (UDs); (II) to discuss organ-sparing approaches and their impact on oncological and functional outcomes in women; (III) to discuss the impact of RC on HRQOL and sexual function in women. METHODS: We performed a non-systematic literature review of the available publications in the PubMed database. KEY CONTENT AND FINDINGS: Over the past years, gender differences in oncological and functional outcomes after RC have received increased attention. According to the currently available literature, organ-sparing approaches can be safely performed in well-selected women without negatively impacting oncological outcomes. The orthotopic neobladder is feasible and oncologically safe in well-selected and informed women. The choice of the UD should be based on comprehensive counseling and the patient's comorbidities and preferences. There still is a lack of data on sexual recovery after the different surgical approaches aimed to mitigate sexual dysfunction in women undergoing RC. CONCLUSIONS: Pre-and post-operative counseling and support of females undergoing RC regarding their expectations and experiences in terms of quality of life and functional and sexual outcomes are currently insufficient. Well-designed studies in this field are necessary to further improve outcomes of women treated with RC with an overarching aim to close the gender gap in managing women with bladder cancer.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Laukhtina, Ekaterina $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
700    1_
$a Pradere, Benjamin $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Department of Urology, La Croix Du Sud Hospital, Quint-Fonsegrives, France
700    1_
$a Pallauf, Maximilian $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Department of Urology, University Hospital Salzburg, Paracelsus Medical University Salzburg, Salzburg, Austria
700    1_
$a Klemm, Jakob $u Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Fisch, Margit $u Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan $u Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria $u Department of Urology, Weill Cornell Medical College, New York, NY, USA $u Department of Urology, University of Texas Southwestern, Dallas, TX, USA $u Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Rink, Michael $u Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
773    0_
$w MED00201296 $t Translational andrology and urology $x 2223-4691 $g Roč. 11, č. 11 (2022), s. 1598-1610
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36507477 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230119 $b ABA008
991    __
$a 20230127131131 $b ABA008
999    __
$a ok $b bmc $g 1889477 $s 1182710
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2022 $b 11 $c 11 $d 1598-1610 $e - $i 2223-4691 $m Translational andrology and urology $n Transl Androl Urol $x MED00201296
LZP    __
$a Pubmed-20230119

Najít záznam

Citační ukazatele

Možnosti archivace